Crotonaldehyde BSA Conjugate

Crotonaldehyde BSA Conjugate is used to study the impact of lipid peroxidation-derived aldehydes on neural function. Crotonaldehyde, a byproduct of oxidative stress and environmental exposure, forms stable adducts with lysine residues, altering protein structure and function. In the brain, crotonaldehyde accumulation is associated with mitochondrial dysfunction, impaired proteostasis, and neuroinflammation. These effects are implicated in the pathogenesis of neurodegenerative disorders, including Alzheimer’s and Parkinson’s disease. The BSA conjugate facilitates the detection of crotonaldehyde-protein adducts in biological samples, enabling researchers to quantify oxidative damage and evaluate the efficacy of detoxification pathways or antioxidant therapies.

Crotonaldehyde BSA Conjugate, Crotonaldehyde-BSA Conjugate, Crotonaldehyde (BSA) Conjugate, CRA BSA Conjugate, CRA-modified BSA, Crotonaldehyde-modified BSA, (2E) -but-2-enal BSA Conjugate, Crotoinic aldehyde BSA Conjugate, β-Methacrolein BSA Conjugate, β-Methyl acrolein BSA Conjugate, 2-butenal BSA Conjugate, Propylene aldehyde BSA Conjugate, Crotonaldehyde Bovine Serum Albumin Conjugate, Crotonaldehyde-Bovine Serum Albumin Conjugate, Crotonaldehyde (Bovine Serum Albumin) Conjugate, CRA Bovine Serum Albumin Conjugate, CRA-modified Bovine Serum Albumin, Crotonaldehyde-modified Bovine Serum Albumin, (2E) -but-2-enal Bovine Serum Albumin Conjugate, Crotoinic aldehyde Bovine Serum Albumin Conjugate, β-Methacrolein Bovine Serum Albumin Conjugate, β-Methyl acrolein Bovine Serum Albumin Conjugate, 2-butenal Bovine Serum Albumin Conjugate, Propylene aldehyde Bovine Serum Albumin Conjugate